Queens Hospital

Romford, Essex RM7 OAG

0 studies enrolling now · 7 studies all time

What they study most

Cardiovascular Disease, Churg Strauss Syndrome, Colorectal Adenocarcinoma, Colorectal Cancer, Colorectal Cancer Metastatic, Colorectal Neoplasms, Giant Cell Arteritis, Lupus Erythematosus, Systemic, Microscopic Polyangiitis, Neoplasm, Colorectal, Polyarteritis Nodosa, Takayasu Arteritis

Studies at this site

• A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis — Completed
• A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal Cancer — Stopped early
• An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) — Completed
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II) — Stopped early
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis — Status unconfirmed